Explanation of Revisions 2021

Attachment 11. Explanation of Revisions

National HIV Prevention Program Monitoring and Evaluation Data

OMB No. 0920-0696 (Expiration 10/31/2021)

CDC is requesting the following revisions to adjust the variables in the following ways:

• Remove 47 variables associated with the PS15-1502 Community-based organization flagship funding announcement and health departments transitioning from flagship funding announcement PS12-1201 to PS18-1802 in 2018. (Attachment 5B)

• Add the variable value “PS20-2010” as an option for the variable “Program Announcement” (X137).

• Add the variable value “PS21-2102” as an option for the variable “Program Announcement” (X137).

• Add the variable value “Self-testing” as an option for the variable “Site Type” (S04)

National HIV Prevention Program Monitoring and Evaluations (NHM&E) (OMB 0920-0696, Exp. 10/31/2021)

Variables Removed (N=47)

	Variable Number	Variable Name	Variable Definition
Client
1	G124a	Specify Current Gender Identity	The additional specification of Current Gender Identity if G124 = 89 "Additional (specify)".
2	G200_1	Client Behavioral Risk Profile	An indication of whether the client was asked about behavioral risk factors and why behavioral risk data may not be available. A risk may have been identified during the 12 month recall period; a risk may not have been identified during the 12 month recall period; the provider may not have asked the client about his or her risks; or, the client was asked but declined to provide behavioral risk information.
3	G205	Self-Reported HIV Test Result	The client's self-reported result from his/her most recent HIV test.
4	G211_08	Share Drug Injection Equipment	The client self-reported whether or not he/she shared hypodermic needles, syringes, or other injection equipment within the last 12-months. This variable should only be completed if client has reported injection drug use (i.e., G211_01 Injection Drug Use = "Yes").
5	G212	Additional Client Risk Factors	If the client's risk factors in the past 12 months involve anal or vaginal sexual activity, these are additional factors that further describe the client's sexual risk for HIV exposure and/or transmission.
6	G217a	Vaginal or Anal Sex without a Condom with a Male	The client self-reported having unprotected vaginal or anal sex with a male in the past 12 months.
7	G217b	Vaginal or Anal Sex without a Condom with a Female	The client self-reported having unprotected vaginal or anal sex with a female in the past 12 months.
8	G217c	Vaginal or Anal Sex without a Condom with a Transgender Person	The client self-reported having unprotected vaginal or anal sex with a transgender person in the past 12 months.
9	G218a	Vaginal or Anal Sex with a Male IDU	The client self-reported having vaginal or anal sex with an identified IDU male partner in the past 12 months.
10	G218b	Vaginal or Anal Sex with a Female IDU	The client self-reported having vaginal or anal sex with an identified IDU female partner in the past 12 months.
11	G218c	Vaginal or Anal Sex with a Transgender IDU	The client self-reported having vaginal or anal sex with an identified IDU transgender partner in the past 12 months.
12	G219a	Vaginal or Anal Sex with HIV-Positive Male	The client self-reported having vaginal or anal sex with an HIV-positive male partner in the past 12 months.
13	G219b	Vaginal or Anal Sex with HIV-Positive Female	The client self-reported having vaginal or anal sex with an HIV-positive female partner in the past 12 months.
14	G219c	Vaginal or Anal Sex with HIV-Positive Transgender Person	The client self-reported having vaginal or anal sex with an HIV-positive transgender partner in the past 12 months.
15	G220	Vaginal or Anal Sex with MSM (female only)	The client self-reported having vaginal or anal sex with identified MSM partner in the past 12 months.
16	G223	Vaginal or Anal Sex with an IDU (PS only)	The client self-reported having vaginal or anal sex with an identified IDU partner in the past 12 months.
Partner Services
17	PCR108	Date of Report	The date on which an index client was newly reported to surveillance as being infected with HIV. Persons reported to surveillance have not previously been reported to the same health department surveillance unit.
18	PCR109	Reported to Surveillance	An indication of whether or not the index client's HIV case was reported to surveillance.
19	PCR200	Date Collected	The date on which information about the partner is initially collected. Information includes partner type, demographic and risk behaviors of the partner.
20	PCR202a	Local PS ID	An alpha-numeric identification that is unique to each partner. Each local PS ID is associated with a specific PS case number (PCR101).
21	PCR209	Notification Plan	The method that will be used to inform the partner that he or she has been potentially exposed to HIV.
Testing
22	X103	Test Technology	A description of the type of test or test methods used to screen for HIV antibodies.
23	X104	HIV Test Election	An indication of whether the test is linked to a name or is anonymous.
24	X110	Test Result	The outcome of the current HIV test.
25	X115	If Result Not Provided, Why	An explanation for why the HIV test result was not provided to the client.
26	X136	In Surveillance System or Records	Information obtained via surveillance system or records that verifies whether or not a client who has tested positive, with a conventional, RNA, NAAT or other non-rapid test, was previously reported to your jurisdiction’s surveillance department as a new HIV case.
27	X137-1	Specify Program Announcement/Strategy	A specification of the funding source for the HIV preention service if ’98- Other, CDC-funded’ or '99 - Other, non-CDC funded' was selected in X137 Program Announcement.
28	X303a	Specify Reason for Unsuccessful Attempt	A specification for why the client was not located if X303--89 Other (specify) is selected.
29	X502	Time Period for Recall (in months)	The period of time between 1 and 12 months for which the client is asked to remember and report his or her number of sex and/or needle-sharing partners.
30	X511a	Total Number of Named Male Partners	The total number of sex or needle-sharing male partners for which there is sufficient identifying and locating information.
31	X511b	Total Number of Named Female Partners	The total number of sex or needle-sharing female partners for which there is sufficient identifying and locating information.
32	X511c	Total Number of Named Transgender Partners	The total number of sex or needle-sharing transgender partners for which there is sufficient identifying and locating information.
33	X602	Previous HIV Test	The partner's self-report of having at least one prior HIV test before these data were collected.
34	X603	Self-Reported HIV Test Result	The client's self-reported test result from his/her most recent HIV test prior to notification.
35	X604	Date of Last HIV Test	The date of the partner's last HIV test.
36	X702	Referral Date	The date that the referral was made for the client.
37	X702a	Reason Client Not Referred to HIV Medical Care	The reason why a referral to HIV medical care for an HIV-positive client was not made.
38	X703_01	Referred To HIV Testing	The client was referred to HIV testing. HIV testing is a diagnostic, laboratory procedure to assess for the presence of HIV antibodies.
39	X703_10	Referred To Medical Care	The client was referred to medical services for (or due to their HIV-positive diagnosis) HIV infection including: evaluation of immune system function and screening, treatment, and prevention of opportunistic infection.
40	X703_14	Referred To Partner Services	The client was referred to Partner Services. Partner Services include a range of available services for newly and previously diagnosed HIV-infected persons, their partners and affected communities. Services may include: informing current and past sex partners that a person who is HIV-infected has identified them as a sex or injection-drug- paraphernalia-sharing partner and advising them to have HIV counseling and testing. Additionally, it can include notifying partners, who may not have suspected that they were at increased risk for HIV that they can be tested for HIV. This enables those who test HIV-positive to receive early medical evaluation, treatment, and prevention services, including risk-reduction counseling.
41	X703_17	Referred To HIV Prevention Services	The client was referred to HIV prevention services. Prevention services are defined as generally any service or intervention directly aimed at reducing risk for transmitting or acquiring HIV infection (e.g., prevention counseling, DEBIs, risk-reduction counseling). It excludes indirect services such as mental health services or housing.
42	X706	Referral Outcome	The current status of the referral based on activities to verify that the service was accessed.
43	X706b	First HIV Medical Care Appointment within 90 Days of HIV Test	Confirmation that a client attended his/her HIV medical care appointment within 90 days of the HIV test date.
44	X713	HIV Test Result	The confirmed outcome of an HIV test conducted on the partner as a result of a referral to HIV testing through Partner Services (PS).This variable is required for PS only.
45	X724	Client Received Prevention Services	Confirmation that a client received prevention services after receiving an HIV-positive test result, from a conventional, RNA/NAAT, rapid or other test. Prevention services is defined as generally any service or intervention directly aimed at reducing risk for transmitting or acquiring HIV infection (e.g., prevention counseling, DEBIs, risk-reduction counseling). It excludes indirect services such as mental health services or housing.
46	X725	Partner Service Interview	The indication that a client was interviewed for Partner Services.
47	X725a	Was the PS Interview within 30 Days of Receiving a Positive HIV Test Result	If a client was interviewed for Partner Services, this is an indication of whether or not he/she was interviewed within 30 days of receiving their HIV-positive test result.

5